Related Article: Kuros Biosciences First Half 2025 Earnings: CHF0.051 loss per share (vs CHF0.006 profit in 1H 2024) - finance.yahoo.com - Sunday, August 17, 2025, 3:24:22 AM Eastern Daylight Time
Target: Kuros Biosciences, US oil and gas companies, financial regulators, and industry oversight agencies
Goal: We call on biotech and energy companies, as well as regulatory bodies, to prioritize environmental sustainability, transparency, and social responsibility in all business operations and future developments.
Recent financial disclosures show that Kuros Biosciences experienced a loss in the first half of 2025, despite strong revenue growth forecasts. Meanwhile, political leaders are pledging to expand fossil fuel extraction, with US oil and gas companies set to benefit. This trajectory threatens to undermine global climate goals and public health, while corporate profits remain prioritized over people and the planet.
We urge all stakeholders—especially those in the biotech and energy sectors—to commit to ethical business practices, climate action, and transparent reporting. Economic growth must not come at the cost of environmental destruction or social inequality. It is time for companies and regulators to listen to the public and take bold action for a just and sustainable future.